What this means: Co-Diagnostics Inc (CODX) gets a very positive evaluation from InvestorsObserver's ranking system.

As of 2020 July 15, Wednesday current price of CODX stock is 17.590$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Co-Diagnostics stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. stock a price target range of . If we look at the company’s 10-day average daily trading volume, we find that it … The average price target is . The CODX stock price is -68.29% off its 52-week high price of $29.72 and 95.19% above the 52-week low of $0.85. Is Co-Diagnostics Inc Stock Undervalued? CODX | Complete Co-Diagnostics Inc. stock news by MarketWatch. Analyst recommendations provided by FactSet shows that the consensus forecast for Co-Diagnostics Inc. (CODX) is a “Buy”. Andrew Francis - July 13, 2020. View real-time stock prices and stock quotes for a full financial overview. About the Codx stock forecast. The Score for CODX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2Million shares traded. 2. The CODX stock price is -68.29% off its 52-week high price of $29.72 and 95.19% above the 52-week low of $0.85. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Updated: May 5, 2020 . Facebook. Pinterest. CODX Co-Diagnostics , Inc. Common Stock ... the consensus EPS* forecast has remained the same over the past week at 1.92 and remained the same over the past month at 1.92 . According to analyst consensus estimates figures, the company’s yearly revenue forecasts for 2020 are expected to hit $93.45 Million, or +43365.1% up from figures reported last year. The consensus among analysts is that Co-Diagnostics, Inc. (CODX) is a Buy stock at the moment, with a …

Source: Shutterstock.

Codx stock forecast. An Overall Rank of 79 means that our … On the other hand, looking at the outlook for the CODX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. WhatsApp. By.
Stocks in this group have gained about 5.41% so far this year, so CODX is performing better this group in terms of year-to-date returns. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. CODX Stock Forecast: All the More Reason to Consider Co-Diagnostics Inc. (CODX) Now.

CODX Stock Analysis Overview . ... Week 26 MDA Breakout Forecast: Short-Term … 00 and the median estimate amounting to . Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. According to present data Codx's CODX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The 3-month trading volume is 6.49 Million shares. CODX stock dropped more than 5% Thursday during the regular trading session, and it has fallen another 7% in early morning trading. The current Co-Diagnostics Inc share price is $17.44. Twitter. View the latest Co-Diagnostics Inc. (CODX) stock price, news, historical charts, analyst ratings and financial information from WSJ. CODX is currently trading in the 20-30% percentile range relative to its historical Stock … H.C. Wainwright, on the other hand, stated in their research note that they expect to see CODX stock at the price of $35, previously predicting a value of $20. 3 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”.

The CODX stock was last observed hovering …

Co-Diagnostics Inc (NASDAQ:CODX) shares gapped down prior to trading on Thursday .

Co-Diagnostics Inc. (NASDAQ: CODX) is 1931.95% higher on its value in year-to-date trading and has touched a low of $0.85 and a high of $29.72 in the current 52-week trading range. 3 of the analysts rate the stock …